PATENT CLAIM ANALYSIS

Application Number: 15752765
Application Type: Utility
Filing Date: 2018-02
Publication Date: 2018-12
Patent Classification: ["424", "093100"]

Abstract:
The present invention relates to in vitro cultured senescent cells, such as epithelial cells, keratinocytes and/or fibroblasts as well as their use in the treatment of tissue regeneration, particularly for the treatment of wounds such as burns or ulcers or the treatment of inflammatory conditions. Optionally, products may be used in combination with further drugs including antimicrobial or antidiabetic agents.

Claim (Index 21):
The method according to  claim 1 , wherein senescence is induced by cell culture stress selected from the group consisting of: cell overgrowth, cell contact inhibition, high cell density, oxidative stress, presence of reactive oxygen species; administration of surfactants or other small molecule inducers of senescence; senescence-inducing administration of mitomycin C or any other chemically-based mitotic inhibitor; or by irradiation with \u03b3-Rays, irradiation with X-Rays, or irradiation with UV light including UVB; or by treatment with cold plasma, radiation or e-beam treatment.

Metadata:
- Claim Count in Document: 7.0
- Percentile: 88.0
- Lexical Diversity: 1.40426
- Patent Class: 424.0
- Transitional Phrase Type: closed
- Component Type: 1
- Foreign Priority: True
- Related Applications: ['15080991', '15455684', '15827539', '15455575', '15647688']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7493325062374051
- 35 USC 102 Novelty (BERT): 0.5044208440543695
- Combined Prediction Score: 0.7248413400191016
- Mean Citation Score: 213.13589
- Max Citation Score: 218.5444
- Similarity Product: 131.28454955034255

Labels:
- Claim Label 101: 1
- Claim Label 102: 0
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 0
- Label 101 Adjusted: 1

Dataset: test